Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07471542) titled 'Copper Supplementation in Cirrhosis' on March 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: University of Washington
Condition:
Cirrhosis
Chronic Liver Disease
Fibrosis
Infection
Intervention:
Dietary Supplement: Copper Gluconate
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: March 15, 2026
Target Sample Size: 30
Countries of Recruitment:
United States
To know more, visit https://clinicaltria...